A global comparison regarding patient access to cancer drugs.
Jönsson
B
B
Stockholm School of Economics, Stockholm, Sweden.
Wilking
N
N
D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D017281:Cost of Illness; D015195:Drug Design; D014943:Global Health; D006297:Health Services Accessibility / Q000706:statistics & numerical data*; D006801:Humans; D008389:Marketing of Health Services; D009026:Mortality / Q000639:trends; D009369:Neoplasms / Q000188:drug therapy* / Q000191:economics / Q000401:mortality; D011379:Prognosis; D012106:Research / Q000639:trends
D000970:Antineoplastic Agents